Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: Application of new methodology

  1. Garnett, S.A.
  2. Martin, M.
  3. Jerusalem, G.
  4. Petruzelka, L.
  5. Torres, R.
  6. Bondarenko, I.N.
  7. Khasanov, R.
  8. Verhoeven, D.
  9. Pedrini, J.L.
  10. Smirnova, I.
  11. Lichinitser, M.R.
  12. Pendergrass, K.
  13. Lindemann, J.P.O.
  14. Di Leo, A.
Revista:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Any de publicació: 2013

Volum: 138

Número: 1

Pàgines: 149-155

Tipus: Article

DOI: 10.1007/S10549-012-2395-8 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus